P-Aminosalicylate Sodium
Formulations: - Oral > Liquid: 5.52 g in sachet (equivalent to 4 g p-aminosalicylic acid) powder for oral solution Indications: - Multi-drug resistant Mycobacterium tuberculosis Source: EML workbook import
MOQ: 1
Kes0.00
Product image unavailable
Ethionamide
Vendor: Marketplace supplier
Formulations:
- Oral > Solid > dispersible tablet: 125 mg
Oral > Solid > tablet: 250 mg
Indications:
- Tuberculous meningitis
- Multi-drug resistant Mycobacterium tuberculosis
Source: EML workbook import
Product metadata will be available once the catalog entry is complete.
Kes0.00
Availability
Supplier and price will be confirmed during RFQ.
Formulations:
- Oral > Solid > dispersible tablet: 125 mg
Oral > Solid > tablet: 250 mg
Indications:
- Tuberculous meningitis
- Multi-drug resistant Mycobacterium tuberculosis
Source: EML workbook import
Similar Products
Protionamide
Indications: - Multi-drug resistant Mycobacterium tuberculosis Source: EML workbook import
MOQ: 1
Kes0.00
Pretomanid
Formulations: - Oral > Solid > tablet: 200 mg Indications: - Multi-drug resistant Mycobacterium tuberculosis Source: EML workbook import
MOQ: 1
Kes0.00
Pyrazinamide
Formulations: - Oral > Solid > dispersible tablet: 150 mg Oral > Solid > tablet: 400 mg; 500 mg Indications: - Tuberculosis Source: EML workbook import
MOQ: 1
Kes0.00
Moxifloxacin
Formulations: - Oral > Solid > tablet: 400 mg Oral > Solid > dispersible tablet: 100 mg Indications: - Tuberculosis - Multi-drug resistant Mycobacterium tuberculosis Source: EML workbook import
MOQ: 1
Kes0.00
Meropenem
Formulations: - Parenteral > General injections > IV: 500 mg in vial (as trihydrate) powder for injection; 1 g in vial (as trihydrate) powder for injection Indications: - Multi-drug resistant Mycobacterium tuberculosis - Neonatal meningitis - Peritonitis (severe) - Peritoneal abscess (severe) - Neutropenia (high-risk) Source: EML workbook import
MOQ: 1
Kes0.00
Sign Up to Our Newsletter→
Ready to amplify your rewards? Drop your email and we'll be in touch soon.